Trenton, August 29, 2023 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the Administration’s announcement of the first ten prescription medicines subject to government price setting: (Read full statement here)
Menu